Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,580 GBX | -0.19% | -3.91% | +8.90% |
Apr. 17 | GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix | MT |
Apr. 17 | GSK: positive clinical results for gonorrhea | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.90% | 80.65B | |
+27.97% | 672B | |
+23.64% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.42% | 211B | |
-0.80% | 203B | |
-10.47% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GSK's Q4 Adjusted Earnings, Sales Increase; Issues 2023 Outlook